首页> 美国卫生研究院文献>other >Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota
【2h】

Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota

机译:通过调节肠道菌群来平衡草药和功能性食品以预防和治疗心脏代谢疾病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It has become apparent that gut microbiota is closely associated with cardiometabolic diseases (CMDs), and alteration in microbiome compositions is also linked to the host environment. Next generation sequencing (NGS) has facilitated in-depth studies on the effects of herbal medicine and functional food on gut microbiota. Both herbal medicine and functional food contain fiber, polyphenols and polysaccharides, exerting prebiotics-like activities in the prevention and treatment of CMDs. The administrations of herbal medicine and functional food lead to increased the abundance of phylum Bacteroidetes, and genus Akkermansia, Bifidobacteria, Lactobacillus, Bacteroides and Prevotella, while reducing phylum Firmicutes and Firmicutes/Bacteroidetes ratio in gut. Both herbal medicine and functional food interact with gut microbiome and alter the microbial metabolites including short-chain fatty acids (SCFAs), bile acids (BAs) and lipopolysaccharides (LPS), which are now correlated with metabolic diseases such as type 2 diabetes (T2D), obesity and non-alcoholic fatty liver disease (NAFLD). In addition, trimethylamine (TMA)-N-oxide (TMAO) is recently linked to atherosclerosis (AS) and cardiovascular disease (CVD) risks. Moreover, gut-organs axes may serve as the potential strategy for treating CMDs with the intervention of herbal medicine and functional food. In summary, a balance between herbal medicine and functional food rich in fiber, polyphenols and polysaccharides plays a vital role in modulating gut microbiota (phylum Bacteroidetes, Firmicutes and Firmicutes/Bacteroidetes ratio, and genus Akkermansia, Bifidobacteria, Lactobacillus, Bacteroides and Prevotella) through SCFAs, BAs, LPS and TMAO signaling regarding CMDs. Targeting gut-organs axes may serve as a new therapeutic strategy for CMDs by herbal medicine and functional food in the future. This review aims to summarize the balance between herbal medicine and functional food utilized for the prevention and treatment of CMDs through modulating gut microbiota.
机译:显而易见,肠道微生物群与心脏代谢疾病(CMD)密切相关,微生物群组成的改变也与宿主环境有关。下一代测序(NGS)促进了对草药和功能食品对肠道菌群的影响的深入研究。草药和功能性食品均含有纤维,多酚和多糖,在预防和治疗CMD中发挥类似益生元的作用。草药和功能性食物的使用会导致拟杆菌门,阿克曼菌属,双歧杆菌,乳杆菌,拟杆菌和普氏杆菌的数量增加,同时降低肠道中的硬菌和硬菌/拟杆菌的比例。草药和功能性食物均会与肠道微生物组相互作用,并改变微生物代谢产物,包括短链脂肪酸(SCFA),胆汁酸(BAs)和脂多糖(LPS),它们现在与诸如2型糖尿病(T2D)的代谢性疾病相关),肥胖和非酒精性脂肪肝(NAFLD)。此外,三甲胺(TMA)-N-氧化物(TMAO)最近与动脉粥样硬化(AS)和心血管疾病(CVD)风险相关。此外,在中草药和功能性食品的干预下,肠器官轴可能成为治疗CMD的潜在策略。总之,草药和富含纤维,多酚和多糖的功能性食品之间的平衡在调节肠道菌群(细菌杆菌门,菌毛菌和菌毛菌/细菌杆菌的比例以及阿克曼属,双歧杆菌,乳杆菌,细菌菌和普氏杆菌)中起着至关重要的作用。有关CMD的SCFA,BA,LPS和TMAO信令。靶向肠-器官轴可能会成为将来通过草药和功能性食品治疗CMD的新策略。这篇综述旨在总结通过调节肠道菌群来预防和治疗CMD的草药和功能性食品之间的平衡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号